Literature DB >> 12441352

Specificity and structural requirements of phospholipase C-beta stimulation by Rho GTPases versus G protein beta gamma dimers.

Daria Illenberger1, Claudia Walliser, Bernd Nurnberg, Maria Diaz Lorente, Peter Gierschik.   

Abstract

Phospholipase C-beta(2) (PLC beta(2)) is activated both by heterotrimeric G protein alpha- and beta gamma- subunits and by Rho GTPases. In this study, activated Rho GTPases are shown to stimulate PLC beta isozymes with the rank order of PLC beta(2) > PLC beta(3) > or = PLC beta(1). The sensitivity of PLC beta isozymes to Rho GTPases was clearly different from that observed for G protein beta gamma dimers, which decreased in the following order: PLC beta(3) > PLC beta(2) > PLC beta(1) for beta(1)gamma(1/2) and PLC beta(2) > PLC beta(1) >>> PLC beta(3) for beta(5)gamma(2). Rac1 and Rac2 were found to be more potent and efficacious activators of PLC beta(2) than was Cdc42Hs. The stimulation of PLC beta(2) by Rho GTPases and G protein beta gamma dimers was additive, suggesting that PLC beta(2) activation can be augmented by independent regulation of the enzyme by the two stimuli. Using chimeric PLC beta(1)-PLC beta(2) enzymes, beta gamma dimers, and Rho GTPases are shown to require different regions of PLC beta(2) to mediate efficient stimulation of the enzyme. Although the catalytic subdomains X and Y of PLC beta(2) were sufficient for efficient stimulation by beta gamma, the presence of the putative pleckstrin homology domain of PLC beta(2) was absolutely required for the stimulation of the enzyme by Rho GTPases. Taken together, these results identify Rho GTPases as novel PLC beta regulators, which mediate PLC beta isozyme-specific stimulation and are potentially involved in coordinating the activation of PLC beta(2) by extracellular mediators in intact cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12441352     DOI: 10.1074/jbc.M208282200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

Review 1.  The phospholipase C isozymes and their regulation.

Authors:  Aurelie Gresset; John Sondek; T Kendall Harden
Journal:  Subcell Biochem       Date:  2012

2.  A signal transduction pathway model prototype I: From agonist to cellular endpoint.

Authors:  Thomas J Lukas
Journal:  Biophys J       Date:  2004-09       Impact factor: 4.033

3.  Expansion of signal transduction by G proteins. The second 15 years or so: from 3 to 16 alpha subunits plus betagamma dimers.

Authors:  Lutz Birnbaumer
Journal:  Biochim Biophys Acta       Date:  2006-12-15

Review 4.  Stimulation of phospholipase Cbeta by membrane interactions, interdomain movement, and G protein binding--how many ways can you activate an enzyme?

Authors:  Guillaume Drin; Suzanne Scarlata
Journal:  Cell Signal       Date:  2007-04-29       Impact factor: 4.315

5.  Phospholipase C isozymes as effectors of Ras superfamily GTPases.

Authors:  T Kendall Harden; Stephanie N Hicks; John Sondek
Journal:  J Lipid Res       Date:  2008-11-24       Impact factor: 5.922

Review 6.  Structural insights into phospholipase C-β function.

Authors:  Angeline M Lyon; John J G Tesmer
Journal:  Mol Pharmacol       Date:  2013-07-23       Impact factor: 4.436

Review 7.  G protein βγ subunits: central mediators of G protein-coupled receptor signaling.

Authors:  A V Smrcka
Journal:  Cell Mol Life Sci       Date:  2008-07       Impact factor: 9.261

8.  Molecular mechanisms of phospholipase C β3 autoinhibition.

Authors:  Angeline M Lyon; Jessica A Begley; Taylor D Manett; John J G Tesmer
Journal:  Structure       Date:  2014-12-02       Impact factor: 5.006

Review 9.  G-protein signaling: back to the future.

Authors:  C R McCudden; M D Hains; R J Kimple; D P Siderovski; F S Willard
Journal:  Cell Mol Life Sci       Date:  2005-03       Impact factor: 9.261

10.  Differential regulation of phospholipase C-beta2 activity and membrane interaction by Galphaq, Gbeta1gamma2, and Rac2.

Authors:  Orit Gutman; Claudia Walliser; Thomas Piechulek; Peter Gierschik; Yoav I Henis
Journal:  J Biol Chem       Date:  2009-12-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.